For the quarter ending 2026-03-31, LFMD has $70,124,668 in assets. $55,087,822 in debts.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash | 34,478,137 | 23,785,771 | 36,228,305 | |
| Accounts receivable | 9,855,117 | 9,244,321 | 7,330,129 | |
| Product deposit | 331,525 | 370,518 | 251,000 | |
| Inventory, net | 3,177,136 | 3,432,382 | 3,251,355 | |
| Other current assets | 3,855,131 | 4,252,613 | 1,964,974 | |
| Total current assets | 51,697,046 | 41,085,605 | 49,025,763 | |
| Total equipment, at cost | 4,257,721 | - | - | |
| Accumulated depreciation | 1,997,284 | - | - | |
| Equipment, net | 2,260,437 | 2,584,829 | 2,050,318 | |
| Right of use assets, net | 5,055,090 | 5,578,992 | 5,822,907 | |
| Capitalized software, net | 10,881,678 | 15,175,634 | 14,837,946 | |
| Intangible assets, net | 230,417 | 1,558,318 | 1,827,768 | |
| Total non-current assets | 18,427,622 | 24,897,773 | 24,538,939 | |
| Total assets | 70,124,668 | 65,983,378 | 73,564,702 | |
| Current portion of long-term debt | - | - | 11,960,784 | |
| Accounts payable | 21,653,122 | 19,554,735 | 24,292,870 | |
| Accrued expenses | 15,244,963 | 22,079,805 | 14,946,499 | |
| Current operating lease liabilities | 670,825 | 673,482 | 541,981 | |
| Deferred revenue | 12,016,840 | 14,355,531 | 11,790,024 | |
| Total current liabilities | 49,585,750 | 56,663,553 | 63,532,158 | |
| Noncurrent operating lease liabilities | 5,502,072 | 5,851,673 | 6,032,847 | |
| Long-term debt, net | - | - | 3,517,317 | |
| Contingent consideration | - | 100,000 | 100,000 | |
| Total liabilities | 55,087,822 | 62,615,226 | 73,182,322 | |
| Series a preferred stock, 0.0001 par value 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, 35.8 million as of march 31, 2026 and december 31, 2025 | 140 | 140 | 140 | |
| Common stock, 0.01 par value 100,000,000 shares authorized, 47,632,707 and 46,760,016 shares issued, 47,529,667 and 46,656,976 outstanding as of march 31, 2026 and december 31, 2025, respectively | 476,327 | 466,864 | 451,412 | |
| Additional paid-in capital | 252,976,314 | 248,801,209 | 236,426,008 | |
| Accumulated deficit | -238,252,234 | -247,790,178 | -238,496,413 | |
| Treasury stock, 103,040, at cost, as of march 31, 2026 and december 31, 2025 | 163,701 | 163,701 | 163,701 | |
| Total stockholders equity | 15,036,846 | 1,314,334 | -1,782,554 | |
| Non-controlling interest | - | 2,053,818 | 2,164,934 | |
| Total stockholders equity (deficit) | - | 3,368,152 | 382,380 | |
| Total liabilities and stockholders equity | 70,124,668 | 65,983,378 | 73,564,702 | |
LifeMD, Inc. (LFMD)
LifeMD, Inc. (LFMD)